论文部分内容阅读
A New Recyclable Ditribromide Reagent and its Usages in Synthesis
【机 构】
：
School of Pharmacy,Health Science Center,Xian Jiaotong University,Xi'an,710061,P.R.China
【出 处】
：
2015年全国药物化学学术会议暨第五届中英药物化学学术会议
【发表日期】
：
2015年3期
其他文献
In continuation of our efforts toward the discovery of potent HIV-1 NNRTIs with novel structures,a series of novel imidazopyridinylthioacetanilide derivatives were rationally designed via scaffold hop
肾上腺素能受体，包含α1-，α2-和β-三种亚型，主要介导儿茶酚胺的功能效应，在交感神经系统活动中起着重要的作用。近来研究发现α1-肾上腺素能受体在人类良性前列腺增生和前列腺癌等疾病相关细胞中大量存在。
微管蛋白是抗肿瘤药物研究的有效靶点之一，以紫杉醇为代表的微管蛋白抑制剂是临床最有效的抗肿瘤药物。紫杉醇、埃坡霉素等作用于紫杉醇(埃坡霉素)结合位点，能够抑制微管蛋白的解聚，使微管结构稳定；而长春碱和秋水仙碱则通过各自的作用位点，抑制微管蛋白的聚合。
Labeling of human Ether-a-go-go-Related Gene(hERG)potassium channel with fluorescent probe has been becoming an essential tool in hERG-associated studies.[1,2] In this research,three small-molecule fl
Design,synthesis and preliminary biological evaluation of pyrrolidine derivatives as Mcl-1 inhibitor
The B-cell lymphoma(Bcl-2)family proteins are potential targets for cancer treatment.In our studies,a series of pyrrolidine derivatives were developed as potent myeloid cell leukemia sequence 1(Mcl-1)
Histone deacetylase(HDAC)has emerged as an attractive target for the development of antitumor agents during the past decade.[1] In our previous study,we designed and synthesized a novel series of N-hy
Discovery of etravirine-JLJ506 hybrids as potent HIV-1 NNRTIs through structure-guided molecular hyb
The long-term usage of HIV-1 non-nucleoside reverse transcriptase inhibitors(NNRTIs)usually leads to rapid emergence of mutant stains and severe side effects.
A series of novel 6-substituted diarylpyridine derivatives targeting the entrance channel of the NNRTI binding pocket(NNIBP)of HIV-1 RT was designed through a molecular hybridization strategy.
Unexpected intermolecular N-N acyl shift from 1-acetyl-4-chloro-1H-indazoles to primary aromatic ami
会议
Forty-two compounds(series 8,9 and 10)incorporated with diacylated piperazine have been synthesized and evaluated as novel Bcr-Abl inhibitors based on six-atom linker.